EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Profit After Tax History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit After Tax | ₹528 Cr | ₹562 Cr | ₹703 Cr | ₹419 Cr | ₹101 Cr |
What is the latest Profit After Tax of EMCURE PHARMACEUTICALS ?
Year | Profit After Tax |
---|---|
Mar2024 | ₹528 Cr |
Mar2023 | ₹562 Cr |
Mar2022 | ₹703 Cr |
Mar2021 | ₹419 Cr |
Mar2020 | ₹101 Cr |
How is Profit After Tax of EMCURE PHARMACEUTICALS Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹528 Cr | -6.10 | |
Mar2023 | ₹562 Cr | -20.03 | |
Mar2022 | ₹703 Cr | 67.84 | |
Mar2021 | ₹419 Cr | 316.06 | |
Mar2020 | ₹101 Cr | - |
Compare Profit After Tax of peers of EMCURE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EMCURE PHARMACEUTICALS | ₹25,947.3 Cr | 5.6% | 2.3% | -0.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,667.0 Cr | 1.8% | 3.4% | 7.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,131.0 Cr | -0.7% | 3.8% | 49.3% | Stock Analytics | |
CIPLA | ₹119,745.0 Cr | -0.2% | -1.1% | -2.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,603.0 Cr | 5.8% | 8.6% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,429.0 Cr | 0.7% | -3.8% | -7.3% | Stock Analytics |
EMCURE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EMCURE PHARMACEUTICALS | 5.6% |
2.3% |
-0.6% |
SENSEX | -1.1% |
0.8% |
2.2% |
You may also like the below Video Courses